Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head‐to‐Head Comparison With Fed‐Batch
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In this study, the authors compared the impacts of fed‐batch and perfusion platforms on process and product attributes for IgG1‐ and IgG4‐producing cell lines. A “plug‐and‐play” approach is applied to both platforms at bench scale, using commercially available basal and feed media, a standard feed strategy for fed‐batch and ATF filtration for perfusion. Product concentration in fed‐batch is 2.5 times greater than perfusion, while average productivity in perfusion is 7.5 times greater than fed‐batch. PCA reveals more variability in the cell environment and metabolism during the fed‐batch run. LDH measurements show that exposure of product to cell lysate is 7–10 times greater in fed‐batch. Product analysis shows larger abundances of neutral species in perfusion, likely due to decreased bioreactor residence times and extracellular exposure. The IgG1 perfusion product also has higher purity and lower half‐antibody. Glycosylation is similar across both culture modes. The first perfusion harvest slice for both product types shows different glycosylation than subsequent harvests, suggesting that product quality lags behind metabolism. In conclusion, process and product data indicate that intra‐lot heterogeneity is decreased in perfusion cultures. Additional data and discussion is required to understand the developmental, clinical and commercial implications, and in what situations increased uniformity would be beneficial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-density mammalian cell cultures in stirred-tank bioreactor without external pH control
Xu, S., & Chen, H. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.06.019 · Cited by 99
Zhuang, C., Zheng, C., Chen, Y., Huang, Z., Wang, Y., Fu, Q., Zeng, C., Wu, T., Yang, L., & Qi, N. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8312-7 · Cited by 16
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Mahal, H., Branton, H., & Farid, S. S. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27774 · Cited by 71
Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications
MacDonald, M. A., Nöbel, M., Roche Recinos, D., Martínez, V. S., Schulz, B. L., Howard, C. B., Baker, K., Shave, E., Lee, Y. Y., Marcellin, E., et al. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1998821 · Cited by 55
“Many of these newer publications are also very detailed compared to earlier works, benefiting from a history of developments in understanding product–quality attributes, and repeatedly highlight the capabilities of perfusion culture to produce high quality products [18,126,145].”
BackgroundInfluentialPerfusion‐Based Production of rAAV via an Intensified Transient Transfection Process
Nguyen, T. N. T., Park, D., Canova, C. T., Sangerman, J., Srinivasan, P., Ou, R. W., Barone, P. W., Neufeld, C., Wolfrum, J. M., Springs, S. L., et al. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28967 · Cited by 10
“This model recalibration is reasonable given the differences in cell culture media and bioreactor conformation between studies, both of which have been shown to impact cell growth and death (Mendes et al. 2022; Walther et al. 2019).”
Leong, J., Tang, W. Q., Chng, J., Ler, W. X., Manan, N. A., Sim, L. C., Zheng, Z. Y., Zhang, W., Walsh, I., Zijlstra, G., et al. (2024) · Biotechnology Journal · doi:10.1002/biot.202400092 · Cited by 9
Metadata
- Authors
- Walther, J., Lu, J., Hollenbach, M., Yu, M., Hwang, C., McLarty, J., & Brower, K.
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2018-06-25
- Volume
- 14
- Issue
- 2
- Pages
- e1700733-e1700733
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2805514309
- Cited by
- 93
- References
- 2
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.